Protocol for a double-blind randomised controlled trial of low dose intradermal grass pollen immunotherapy versus a histamine control on symptoms and medication use in adults with seasonal allergic rhinitis (PollenLITE)

BACKGROUND: Subcutaneous immunotherapy with high dose grass pollen (typically microgram quantities) was first described over 100 years ago. This treatment suppresses allergen-induced cutaneous late responses, with lesser effects on early responses. We previously reported that repeated 2-weekly intra...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Slovick, Anna, Douiri, Abdel, Kelly, Joanna, Guerra, Andrea, Muir, Rachel, Tsioulos, Konstantinos, Murphy, Caroline, Shamji, Mohamed H, Ying, Sun, Durham, Stephen R, Till, Stephen J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Study Protocol
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3765857/
https://ncbi.nlm.nih.gov/pubmed/23965180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-7022-3-27
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak